2025 Joint Chairmen's Reports​

• ​Report on Managed Care Organization Medical Loss Ratios 
• Report on Medicare and Medicaid Coverage of Dually Eligible End-Stage Renal Disease (ESRD) Patients in Marylan​d
• Evaluation of Primary Care Program and Initiatives in Coordination with AHEAD Model​
• Quarterly reports on Medicaid and MCHP enrollment and applications
1. ​​Quarter 2​​

2025 Legislative Reports​

• Report Required by Health - General §15-103.8 and HB 684 - Ch. 691 of the Acts of 2022; IMD Services for Medicaid Participants with Serious Mental Illness and Substance Use Disorder​
• HB 4​89 (Ch. 321 of the Acts of 2016) and​ Health – General §15-1005(a) – Senior Prescription Drug Assistance Program Annual Report – 2024 Program Year​​​
• Report Pursuant to Ch. 733 of the Acts of 2025 - Nursing Home Costs - 2025 Report
• Report Required by Health-General Article § 8-1102(c) – 2025 Report on Continued Analysis of Medications to Treat Opioid Use Disorder – Preferred and Non-Preferred Medications (MSAR# 14171)​
  
  

2024 Joint Chairmen's ​Reports

• Report on Federal Rule on Long-Term Care Data Reporting
  
• ​​Quarterly R​eports on Medicaid and MCHP Enrollment and Applications 
1. ​​​Quarter 1​​
   
2. ​Quarter 2​​
   
3. Quarter 3​
   
4. Quarter 4​
   
• Report on End The Wait Initiatives Related to Provider Capacity​
• Report on Recoupment, Forgiveness and ASO Transition​
• Report on Reimbursement for Maternal Fetal Medicine​
  
• Report on Medicaid Reimbursement of School-Based Behavioral Health Services​
  
• Report on Recruitment and Retention ​​of Anesthesiologists in Maryland​​
• Report on Nursing Home Participation in Medicaid and Revenue by Geographic Area​

2024 Legislative Reports

• Report Required by Health - G​eneral §15-103.8 and HB 684 - Ch. 691 of the Acts of 2022- IMD Services for Medicaid Participants with Serious Mental Illness and Substance Use Disorder​
• Report Required by Health-General Article § 8-1102(c) – 2024 Report on Analysis of 

  Medications to Treat Opioid Use Disorder – Preferred and Non-Preferred Medications

   

  (MSAR# 14171)​
• ​Report Required By Health – General Article § 15–114.1 and Chapter 668 of the Acts of 2022: Maryland Medical Assistance Program – Emergency Service Transporters – Reimbursement (MSAR # 14117)​
  
• Health General Article § 19-310.1(f) - FY 2024 Nursing Home Health Quality Assessment Implementation Annual Report (MSAR #10382)​​
• Report required by Health General Article § 13-2504(b): 2024 Annual Oral Health Legislative Report
  
• Report Required By HB 189/SB 371 (Ch. 865/864 of the Acts of 2024) – Maryland Medical Assistance Program – Personal Care Aides – Wage Reports – Report on the Final Ensuring Access to Medicaid Services Federal Rule and Plans or Steps that ​MDH will Take to Operationalize the Rule (MSAR #15140)
  
• Report on the “L” codes utilization within the All-Payer Claims Database and cost impact of Orthoses coverage as per the requirements of SB 614 (Chs. 822 and 823 of the ​Acts of 2024) (MSAR # 15605)​
• Report Pursuant to SB790/HB 822 - Ch. 845 and 846 of the Acts of 2024: Report on Maryland Medical Assistance Program - Employed Individuals With Disabilities (MSAR #15745)
• Report Pursuant to HB 290 (Ch. 377 of the Acts of 2023): 2023 Report on Dental Provider Participation in Maryland Healthy Smiles Dental Program (MSAR #14695)
• HB 290 - Public Health – Dental Services – Access (Chapter 377 of the Acts of 2023), Study on Providing Reimbursement for Services Provided by a Certified Community Health Worker (MSAR# 14986)
• Report pursuant to Chapters 322 and 323 of the Acts of 2023, Maryland Medical Assistance Program and Health Insurance – Required Coverage for Biomarker Testing (MSAR #14913)​
• Report Required by SB 600, Ch. 903/HB 103, Ch. 904 of the Acts of 2024 on Maryland Medical Assistance Program - Dental Services - Coverage and Rate Study (MSAR #15643)
• ​SB 460, Ch. 252/HB 283, Ch. 253 of the Acts of 2023 - Annual Report on Geographic Access to Gender-Affirming Treatment in the Maryland Medical Assistance Program (MSAR # 14693)
• ​SB 620/HB946 (Ch. 426 and 427 of the Acts of 2004) and Health – General §15-135(g) – Report on Home and Community-Based Long-Term Care Services (MSAR #8421)​
  
• SB 594, Ch. 778/HB 986, Ch. 777 of the Acts of 2024) - Maryland Medical Assistance Program - Coverage for the Treatment of Obesity - Required Study (MSAR# 15768)​
• Health General Article 

  § 15-1103 - Public Health - Home and Community-Based Services for Children and Youth 2024 Report (MSAR #14577)
• ​

  HB 70 (Ch. 656 of the Acts of 2009); Health – General § 15-103.5; and Insurance

  Article § 19-807(d)(2) — Annual Report on the Maryland Medical Assistance Program and 

  the Maryland Children’s Health Program – Provider Reimbursement Rates
  

  ​

• Report on Employed Individuals with Disabilities (EID) Program Eligibility Requirements and Expenditures​​
  
• Implementation of a Reimbursement Rate Increase for Dental Services Covered by Medicaid
• Report on Current Medicaid Rate Structures & Rate-Setting Studies​
• Report on Remote Services Model for Ad​ult Medical Day Care Clients and Centers​
• Report on Community First Choice and Community Options Waiver Financial and Registry Data (August)
  
• Report on Community First Choice and ​​Community Options Waiver Financial and Registry Data​ (December)​
  
• Report on a Closed-Loop Referral Platform for Medicaid and Maryland Children’s Health Program Participants’ Health-Related Social Needs
• Report on Health Care and Dental Coverage for Undocumented Immigrants​
• Quarterly Report with Data and Status Updates Related to Redeterminations - Quarter 2
• ​​Quarterly Report with Data and Status Updates Related to Redeterminations - Quarter 3
  
1. Attachment 1: Medicaid Data Dashboard
2. Attachment 2: JCR Requested Metrics
3. Attachment 3: Unwinding Data FAQs
   
4. Attachment 4: Medicaid Check-In Presentation​
• Quarterly Report with Data and Status Updates Related to Redeterminations - Quarter 4​
1. ​Attachment 1: Medicaid Data Dashboard
2. Attachment 2: JCR Requested Metrics
3. Attachment 3: Unwinding Data FAQ 
4. Attachment 4: Medicaid Check-In Presentation
   
5. Attachment 5: Medicaid Redetermination Comprehensive Communications Summary, September 2023​​
• Reports on​ Home- and Community-Based Options (Community Options) Waiver Care Plan Backlog:
  
• ​July 2023 Report
  
• August 2023 Report
• September 2023 Report
• October 2023 Report
  
• November 2023 Report
• December 2023 Report
  
• January 2024 Report​
  
• February 2024 Report
  
• March 2024 Report
  
• April 2024 Report​
  
• May 2024 Report​​
  
• June 2024 Report​
  
• SPDAP annual report - 2023
  
• SPDAP annual report - 2024​
  
• Report on CFC Program and Community Options Waiver Financial and Registry Data​
• Report on Recoupment, Forgiveness and ASO Transition
• Implementation of Recommendations from Financial Compliance Report​​

2023 Legislative Reports

• FY 2023 Nursing Home Health Quality Assessment Implementation Annual Report (MSAR #10382) -Health General Article § 19-310.1(f)
• Report on Personal Care Aides Providing Home Care at Residential Services Agencies -HB544/SB600, Ch. 673/674 (2022) (MSAR # 14327) 
• Report on Managed Care Organizations and Prescription Drug Claims - HB 382, Ch. 217 (2023​)​​​
• 2023 Annual Report on the Maryland Medical Assistance Program and the Maryland Children’s Health Program –Provider ​Reimbursement Rates (MSAR #7893)​​
  
• Survey and Regional Needs Assessment - Final Report on the Survey of Hospitals to Identify the Availability of Hospital Operating Room Resources for Dentist Use (MSAR # 14852)​​
• 2023 Annual Oral Health Legislative Report, Health-General Article, Section 13-
   
  2504(b) and HB 70 (Chapter 656 of the Acts of 2009) (MSAR #10381)
  
  
  
• Report required by Health-General Article § 15-1103 and Ch. 378/379 of the Acts of 2023 - 2023 Annual Report on En​rollment in the 1915(i) Model and Child and Adolescent Case Management Services (MSAR ​#14577)​
• Report Required by Health-General Article § 8-1102(c) and Ch. 82 and Ch. 83 of the Acts of 2022 – 2023 Report on Initial Analysis of Medications to Treat Opioid Use Disorder – Preferred and Non-Preferred Medications (MSAR# 14171)
  
• Report required by Health General §15-135(g) and SB 620/HB946 (Ch. 426 and 427 of the Acts of 2004)

  – 2023 Report on Home- and Community-Based Long-Term Care Services (MSAR # 8421)